chr12-4912182-G-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000217.3(KCNA1):​c.804G>C​(p.Thr268=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.515 in 1,612,204 control chromosomes in the GnomAD database, including 215,863 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 19642 hom., cov: 27)
Exomes 𝑓: 0.52 ( 196221 hom. )

Consequence

KCNA1
NM_000217.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.640
Variant links:
Genes affected
KCNA1 (HGNC:6218): (potassium voltage-gated channel subfamily A member 1) This gene encodes a voltage-gated delayed potassium channel that is phylogenetically related to the Drosophila Shaker channel. The encoded protein has six putative transmembrane segments (S1-S6), and the loop between S5 and S6 forms the pore and contains the conserved selectivity filter motif (GYGD). The functional channel is a homotetramer. The N-terminus of the channel is associated with beta subunits that can modify the inactivation properties of the channel as well as affect expression levels. The C-terminus of the channel is complexed to a PDZ domain protein that is responsible for channel targeting. Mutations in this gene have been associated with myokymia with periodic ataxia (AEMK). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 12-4912182-G-C is Benign according to our data. Variant chr12-4912182-G-C is described in ClinVar as [Benign]. Clinvar id is 21130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-4912182-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.64 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.626 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNA1NM_000217.3 linkuse as main transcriptc.804G>C p.Thr268= synonymous_variant 2/2 ENST00000382545.5 NP_000208.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNA1ENST00000382545.5 linkuse as main transcriptc.804G>C p.Thr268= synonymous_variant 2/24 NM_000217.3 ENSP00000371985 P1
ENST00000640877.1 linkuse as main transcriptn.606+1710G>C intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.508
AC:
76460
AN:
150484
Hom.:
19629
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.460
Gnomad AMI
AF:
0.521
Gnomad AMR
AF:
0.581
Gnomad ASJ
AF:
0.580
Gnomad EAS
AF:
0.645
Gnomad SAS
AF:
0.481
Gnomad FIN
AF:
0.487
Gnomad MID
AF:
0.656
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.528
GnomAD3 exomes
AF:
0.532
AC:
133633
AN:
251292
Hom.:
36097
AF XY:
0.528
AC XY:
71684
AN XY:
135842
show subpopulations
Gnomad AFR exome
AF:
0.455
Gnomad AMR exome
AF:
0.632
Gnomad ASJ exome
AF:
0.590
Gnomad EAS exome
AF:
0.656
Gnomad SAS exome
AF:
0.473
Gnomad FIN exome
AF:
0.487
Gnomad NFE exome
AF:
0.511
Gnomad OTH exome
AF:
0.530
GnomAD4 exome
AF:
0.516
AC:
753596
AN:
1461602
Hom.:
196221
Cov.:
59
AF XY:
0.514
AC XY:
373941
AN XY:
727132
show subpopulations
Gnomad4 AFR exome
AF:
0.461
Gnomad4 AMR exome
AF:
0.625
Gnomad4 ASJ exome
AF:
0.590
Gnomad4 EAS exome
AF:
0.642
Gnomad4 SAS exome
AF:
0.476
Gnomad4 FIN exome
AF:
0.487
Gnomad4 NFE exome
AF:
0.510
Gnomad4 OTH exome
AF:
0.523
GnomAD4 genome
AF:
0.508
AC:
76505
AN:
150602
Hom.:
19642
Cov.:
27
AF XY:
0.510
AC XY:
37388
AN XY:
73348
show subpopulations
Gnomad4 AFR
AF:
0.460
Gnomad4 AMR
AF:
0.581
Gnomad4 ASJ
AF:
0.580
Gnomad4 EAS
AF:
0.645
Gnomad4 SAS
AF:
0.480
Gnomad4 FIN
AF:
0.487
Gnomad4 NFE
AF:
0.510
Gnomad4 OTH
AF:
0.532
Alfa
AF:
0.480
Hom.:
5126
Bravo
AF:
0.519
Asia WGS
AF:
0.576
AC:
1998
AN:
3478
EpiCase
AF:
0.524
EpiControl
AF:
0.526

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 31, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 77% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 72. Only high quality variants are reported. -
Episodic ataxia type 1 Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 07, 2018- -
Hereditary episodic ataxia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.4
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2227910; hg19: chr12-5021348; COSMIC: COSV66836881; COSMIC: COSV66836881; API